Zinc-dependent interaction between JAB1 and Pre-S2 mutant large surface antigen of hepatitis B virus and its implications for viral hepatocarcinogenesis

Journal of Virology

Volumn 87, Issue 23, 2013, Pages 12675-12684

  Hsu, Jye Lin ^a,d   Chuang, Woei Jer ^a   Su, Ih Jen ^a,b   Gui, Wen Jun ^c   Chang, Yu Ying ^a   Lee, Yun Ping ^a   Ai, Yu Lin ^a   Chuang, David T ^c   Huang, Wenya ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; HEPATITIS B SURFACE ANTIGEN; HISTIDINE; JUN ACTIVATION DOMAIN BINDING PROTEIN 1; UNCLASSIFIED DRUG; ZINC ION;

ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME DEGRADATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; VIRUS CARCINOGENESIS; VIRUS MUTANT;

AMINO ACID MOTIFS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; PEPTIDE HYDROLASES; PROTEIN BINDING; PROTEIN PRECURSORS; ZINC;

EID: 84887208273     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01497-13     Document Type: Article

References (39)

1. Gudat F, Bianchi L, Sonnabend W, Thiel G, Aenishaenslin W, Stalder GA. 1975. Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B. Lab. Invest. 32:1-9.
2. Shafritz DA, Kew MC. 1981. Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomas. Hepatology 1:1-8.
3. Ibarra MZ, Mora I, Bartolome J, Porres JC, Carreno V. 1989. Detection of proteins encoded by the pre-S region of hepatitis B virus in the sera of HBsAg carriers:relation to viral replication. Liver 9:153-158.
4. Fan YF, Lu CC, Chang YC, Chang TT, Lin PW, Lei HY, Su IJ. 2000. Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced disease of chronic hepatitis B virus infection. J. Gastroenterol. Hepatol. 15:519-528.
5. Fan YF, Lu CC, Chen WC, Yao WJ, Wang HC, Chang TT, Lei HY, Shiau AL, Su IJ. 2001. Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBS infection. Hepatology 33:277-286.
6. Wang HC, Wu HC, Chen CF, Lei HY, Su IJ. 2003. Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am. J. Pathol. 163:2441-2449.
7. Su IJ, Wang HC, Wu HC, Huang W. 2008. Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection. J. Gastroenterol. Hepatol. 23:1169-1174.
8. Tsai HW, Lin YJ, Lin PW, Wu HC, Hsu KH, Yen CJ, Chan SH, Huang W, Su IJ. 2011. A clustered ground-glass hepatocyte pattern represents a new prognostic marker for the recurrence of hepatocellular carcinoma after surgery. Cancer 117:2951-2960.
9. Shen FC, Su IJ, Wu HC, Hsieh YH, Yao WJ, Young KC, Chang TC, Hsieh HC, Tsai HN, Huang W. 2009. A Pre-S Gene Chip to detect the pre-S deletions in the hepatitis B virus large surface antigen as a predictive marker for hepatoma risk in the chronic HBV carriers. J. Biomed. Sci. 16:84-91.
10. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. 2006. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130:1153-1168.
11. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, Chang WT, Huang W. 2004. The pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25:2023-2032.
12. Hsieh YH, Hsu JL, Su IJ, Huang W. 2011. Genomic instability caused by hepatitis B virus:into the hepatoma inferno. Front. Biosci. 17:2586-2597.
13. Wang HC, Chang WT, Chang WW, Huang W, Lei HY, Lai MD, Fausto N, Su IJ. 2005. Upregulation of cyclin A and nodular proliferation of hepatocytes induced by a pre-S2 deletion mutant in chronic HBV infection. Hepatology 41:761-770.
14. Kip1 through c-Jun activation domain-binding protein 1. Mol. Cancer Res. 5:1063-1072.
15. Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J. Biol. Chem. 277:2302-2310.
16. Chamovitz DA, Segal D. 2001. JAB1/CSN5 and the COP9 signalosome:a complex situation. EMBO Rep. 2:96-101.
17. Emberley ED, Niu Y, Leygue E, Tomes L, Gietz RD, Murphy LC, Watson PH. 2003. Psoriasin interacts with Jab1 and influences breast cancer progression. Cancer Res. 63:1954-1961.
18. Luo W, Wang Y, Hanck T, Stricker R, Reiser G. 2006. Jab1, a novel protease-activated receptor-2 (PAR-2)-interacting protein, is involved in PAR-2-induced activation of activator protein-1. J. Biol. Chem. 281:7927-7936.
19. Tran HJ, Allen MD, Löwe J, Bycroft M. 2003. Structure of the Jab1/MPN domain and its implications for proteasome function. Biochemistry 42: 11460-11465.
20. Bellare R, Kutach AK, Rines AK, Guthrie C, Sontheimer EJ. 2006. Ubiquitin binding by a variant Jab1/MPN domain in the essential premRNA splicing factor Prp8p. RNA 12:292-302.
21. Cope GA, Suh GSB, Aravind L, Schwarz SE, Zipursky SL, Koonin EV, Deshaies RJ. 2002. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1. Science 298:608-611.
22. Ambroggio XI, Rees DC, Deshaies RJ. 2004. JAMM:a metalloproteaselike zinc site in the proteasome and signalosome. PLoS Biol. 2:E2. doi:10.1371/journal.pbio.0020002.
23. Chou YC, Jeng KS, Chen ML, Liu HH, Liu TL, Chen YL, Liu YC, Hu CP, Chang C. 2005. Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method. J. Virol. 79:1813-1823.
24. Hsu JL, Chen HC, Peng HL, Chang HY. 2008. Characterization of the histidine-containing phosphotransfer protein B-mediated multistep phosphorelay system in Pseudomonas aeruginosa PAO1. J. Biol. Chem. 283:9933-9944.
25. Oh W, Yang MR, Lee EW, Park KM, Pyo S, Yang JS, Lee HW, Song J. 2006. Jab1 mediates cytoplasmic localization and degradation of West Nile virus capsid protein. J. Biol. Chem. 281:30166-30174.
26. Tao H, Liu W, Simmons BN, Harris HK, Cox TC, Massiah MA. 2010. Purifying natively folded proteins from inclusion bodies using Sarkosyl, Triton X-100, and CHAPS. Biotechniques 48:61-64.
27. Kato N, Okayama T, Isawa H, Yuda M, Chinzei Y, Iwanaga S. 2005. Contribution of the N-terminal and C-terminal domains of haemaphysalin to inhibition of activation of plasma kallikrein-kinin system. J. Biochem. 138:225-235.
28. Hsieh YH, Su IJ, Yen CJ, Tsai TF, Tsai HW, Tsai HN, Huang YJ, Chen YY, Ai YL, Kao LY, Hsieh WC, Wu HC, Huang W. 2013. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the prooncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients. Carcinogenesis. 34:475-485.
29. Maret W. 2009. Molecular aspects of human cellular zinc homeostasis: redox control of zinc potentials and zinc signals. Biometals 22:149-157.
30. Maret W. 2012. New perspectives of zinc coordination environments in proteins. J. Inorg. Biochem. 111:110-116.
31. Mekmouche Y, Coppel Y, Hochgrafe K, Guilloreau L, Talmard C, Mazarguil H, Faller P. 2005. Characterization of the ZnII binding to the peptide amyloid-β1-16 linked to Alzheimer's disease. Chembiochem 6:1663-1671.
32. Ilari A, Alaleona F, Petrarca P, Battistoni A, Chiancone E. 2011. The X-ray structure of the zinc transporter ZnuA from Salmonella enterica discloses a unique triad of zinc-coordinating histidines. J. Mol. Biol. 409:630-641.
33. Stray SJ, Ceres P, Zlotnick A. 2004. Zinc ions trigger conformational change and oligomerization of hepatitis B virus capsid protein. Biochemistry 43:9989-9998.
34. Dueber EC, Schoeffler AJ, Lingel A, Elliott JM, Fedorova AV, Giannetti AM, Zobel K, Maurer B, Varfolomeev E, Wu P, Wallweber HJ, Hymowitz SG, Deshayes K, Vucic D, Fairbrother WJ. 2011. Antagonists induce a conformational change in cIAP1 that promotes autoubiquitination. Science 334:376-380.
35. Song AX, Zhou CJ, Peng Y, Gao XC, Zhou ZR, Fu QS, Hong J, Lin DH, Hu HY. 2010. Structural transformation of the tandem ubiquitininteracting motifs in ataxin-3 and their cooperative interactions with ubiquitin chains. PLoS One 5:e13202. doi:10.1371/journal.pone.0013202.
36. Prager K, Wang-Eckhardt L, Fluhrer R, Killick R, Barth E, Hampel H, Haass C, Walter J. 2007. A structural switch of presenilin 1 by glycogen synthase kinase 3β-mediated phosphorylation regulates the interaction with beta-catenin and its nuclear signaling. J. Biol. Chem. 282:14083-14093.
37. Raaf J, Brunstein E, Issinger OG, Niefind K. 2008. The interaction of CK2alpha and CK2beta, the subunits of protein kinase CK2, requires CK2beta in a preformed conformation and is enthalpically driven. Protein Sci. 17:2180-2186.
38. Norris NC, Bingham RJ, Harris G, Speakman A, Jones RP, Leech A, Turkenburg JP, Potts JR. 2011. Structural and functional analysis of the tandem β-zipper interaction of a streptococcal protein with human fibronectin. J. Biol. Chem. 286:38311-38320.
39. Shim JY, Bertalovitz AC, Kendall DA. 2011. Identification of essential cannabinoid-binding domains:structural insights into early dynamic events in receptor activation. J. Biol. Chem. 286:33422-33435.